nodes	percent_of_prediction	percent_of_DWPC	metapath
Norgestimate—PGR—Betamethasone—psoriasis	0.192	0.369	CbGbCtD
Norgestimate—PGR—Dexamethasone—psoriasis	0.112	0.214	CbGbCtD
Norgestimate—Levonorgestrel—Hydrocortisone—psoriasis	0.0993	0.208	CrCrCtD
Norgestimate—ABCC2—Mycophenolate mofetil—psoriasis	0.0815	0.157	CbGbCtD
Norgestimate—Norethindrone—Hydrocortisone—psoriasis	0.0797	0.167	CrCrCtD
Norgestimate—Testosterone Propionate—Hydrocortisone—psoriasis	0.0671	0.141	CrCrCtD
Norgestimate—Progesterone—Hydrocortisone—psoriasis	0.0671	0.141	CrCrCtD
Norgestimate—ABCC2—Cyclosporine—psoriasis	0.0618	0.119	CbGbCtD
Norgestimate—Testosterone—Hydrocortisone—psoriasis	0.0582	0.122	CrCrCtD
Norgestimate—Progesterone—Prednisolone—psoriasis	0.0564	0.118	CrCrCtD
Norgestimate—Testosterone—Prednisolone—psoriasis	0.049	0.103	CrCrCtD
Norgestimate—ABCC2—Dexamethasone—psoriasis	0.0407	0.0783	CbGbCtD
Norgestimate—ABCC2—Methotrexate—psoriasis	0.0327	0.0629	CbGbCtD
Norgestimate—ESR1—ATF-2 transcription factor network—IL23A—psoriasis	0.000146	0.0443	CbGpPWpGaD
Norgestimate—ABCC2—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000146	0.0441	CbGpPWpGaD
Norgestimate—PGR—Ovarian Infertility Genes—VDR—psoriasis	0.000133	0.0403	CbGpPWpGaD
Norgestimate—PGR—Nuclear Receptors—VDR—psoriasis	0.000116	0.0351	CbGpPWpGaD
Norgestimate—ESR1—FOXM1 transcription factor network—TGFA—psoriasis	0.000105	0.0318	CbGpPWpGaD
Norgestimate—PGR—Nuclear Receptor transcription pathway—VDR—psoriasis	9.17e-05	0.0277	CbGpPWpGaD
Norgestimate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.37e-05	0.0253	CbGpPWpGaD
Norgestimate—PGR—Nuclear Receptors—PPARG—psoriasis	8.09e-05	0.0245	CbGpPWpGaD
Norgestimate—ESR1—Estrogen Receptor Pathway—JUN—psoriasis	7.94e-05	0.024	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	7.32e-05	0.0221	CbGpPWpGaD
Norgestimate—ESR1—Estrogen Receptor Pathway—STAT3—psoriasis	6.87e-05	0.0208	CbGpPWpGaD
Norgestimate—ESR1—Nuclear Receptors—VDR—psoriasis	6.81e-05	0.0206	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	6.79e-05	0.0205	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—REL—psoriasis	6.72e-05	0.0203	CbGpPWpGaD
Norgestimate—PGR—Cellular roles of Anthrax toxin—TNF—psoriasis	6.65e-05	0.0201	CbGpPWpGaD
Norgestimate—PGR—Nuclear Receptor transcription pathway—PPARG—psoriasis	6.39e-05	0.0193	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	5.87e-05	0.0178	CbGpPWpGaD
Norgestimate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.84e-05	0.0177	CbGpPWpGaD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	5.42e-05	0.0164	CbGpPWpGaD
Norgestimate—ESR1—Nuclear Receptor transcription pathway—VDR—psoriasis	5.38e-05	0.0163	CbGpPWpGaD
Norgestimate—ESR1—Estrogen signaling pathway—JUN—psoriasis	5.03e-05	0.0152	CbGpPWpGaD
Norgestimate—ESR1—Estrogen signaling pathway—NFKB1—psoriasis	4.84e-05	0.0147	CbGpPWpGaD
Norgestimate—ESR1—Nuclear Receptors—PPARG—psoriasis	4.75e-05	0.0144	CbGpPWpGaD
Norgestimate—ABCC2—NRF2 pathway—TGFA—psoriasis	4.37e-05	0.0132	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	4.07e-05	0.0123	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—IL10—psoriasis	4.06e-05	0.0123	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—TARS—psoriasis	4.06e-05	0.0123	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	3.98e-05	0.012	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—IL4—psoriasis	3.95e-05	0.012	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	3.78e-05	0.0114	CbGpPWpGaD
Norgestimate—ESR1—Nuclear Receptor transcription pathway—PPARG—psoriasis	3.75e-05	0.0113	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	3.72e-05	0.0112	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	3.61e-05	0.0109	CbGpPWpGaD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	3.59e-05	0.0109	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—HLA-A—psoriasis	3.58e-05	0.0108	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—NOS2—psoriasis	3.57e-05	0.0108	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—LEP—psoriasis	3.16e-05	0.00957	CbGpPWpGaD
Norgestimate—ESR1—FOXA1 transcription factor network—JUN—psoriasis	2.99e-05	0.00906	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.78e-05	0.00841	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	2.74e-05	0.00829	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—CARM1—psoriasis	2.65e-05	0.00802	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	2.55e-05	0.00771	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.52e-05	0.00764	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—IFNG—psoriasis	2.44e-05	0.0074	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—IFNG—psoriasis	2.39e-05	0.00723	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—TARS—psoriasis	2.38e-05	0.0072	CbGpPWpGaD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	2.37e-05	0.00718	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—JUN—psoriasis	2.37e-05	0.00716	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—TYK2—psoriasis	2.34e-05	0.00707	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	2.22e-05	0.00672	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	2.22e-05	0.00671	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.16e-05	0.00655	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—JUN—psoriasis	2.11e-05	0.00639	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—JUN—psoriasis	2.06e-05	0.00625	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—NFKB1—psoriasis	2.03e-05	0.00616	CbGpPWpGaD
Norgestimate—ESR1—LKB1 signaling events—TP53—psoriasis	2.01e-05	0.00609	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—NFKB1—psoriasis	1.88e-05	0.00569	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HCAR2—psoriasis	1.88e-05	0.00569	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	1.84e-05	0.00556	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—STAT3—psoriasis	1.69e-05	0.00511	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.66e-05	0.00502	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TAGAP—psoriasis	1.63e-05	0.00493	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—VDR—psoriasis	1.58e-05	0.00479	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—CARM1—psoriasis	1.56e-05	0.00471	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	1.47e-05	0.00444	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—IL6—psoriasis	1.43e-05	0.00433	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	1.4e-05	0.00424	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.4e-05	0.00422	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—TYK2—psoriasis	1.37e-05	0.00415	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—TP53—psoriasis	1.36e-05	0.00412	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—CARM1—psoriasis	1.28e-05	0.00386	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—IL6—psoriasis	1.25e-05	0.00378	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—IL6—psoriasis	1.14e-05	0.00346	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	1.12e-05	0.00338	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—PPARG—psoriasis	1.1e-05	0.00334	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HCAR2—psoriasis	1.1e-05	0.00334	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	1.07e-05	0.00325	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CCL20—psoriasis	9.76e-06	0.00295	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	9.75e-06	0.00295	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TAGAP—psoriasis	9.56e-06	0.00289	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—VDR—psoriasis	9.29e-06	0.00281	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	9.25e-06	0.0028	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	8.9e-06	0.00269	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	8.08e-06	0.00245	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—VDR—psoriasis	7.62e-06	0.00231	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—CARM1—psoriasis	7.49e-06	0.00227	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	7.37e-06	0.00223	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.93e-06	0.0021	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—IL6—psoriasis	6.71e-06	0.00203	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—PPARG—psoriasis	6.48e-06	0.00196	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.11e-06	0.00185	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CCL20—psoriasis	5.73e-06	0.00173	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SOCS1—psoriasis	5.38e-06	0.00163	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—PPARG—psoriasis	5.31e-06	0.00161	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—VDR—psoriasis	4.47e-06	0.00135	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—LEP—psoriasis	3.97e-06	0.0012	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—APOE—psoriasis	3.97e-06	0.0012	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NFKBIA—psoriasis	3.7e-06	0.00112	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SOCS1—psoriasis	3.15e-06	0.000955	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—PPARG—psoriasis	3.12e-06	0.000944	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TYK2—psoriasis	3.03e-06	0.000916	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CXCL8—psoriasis	2.64e-06	0.000798	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—JUN—psoriasis	2.45e-06	0.000742	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NFKB1—psoriasis	2.36e-06	0.000714	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—LEP—psoriasis	2.33e-06	0.000704	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—APOE—psoriasis	2.33e-06	0.000704	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NFKBIA—psoriasis	2.17e-06	0.000656	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—VEGFA—psoriasis	2.14e-06	0.000648	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—STAT3—psoriasis	2.12e-06	0.000641	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TYK2—psoriasis	1.78e-06	0.000538	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TP53—psoriasis	1.62e-06	0.00049	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CXCL8—psoriasis	1.55e-06	0.000468	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IL6—psoriasis	1.48e-06	0.000448	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—JUN—psoriasis	1.44e-06	0.000435	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NFKB1—psoriasis	1.38e-06	0.000419	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—VEGFA—psoriasis	1.26e-06	0.00038	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—STAT3—psoriasis	1.24e-06	0.000376	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TP53—psoriasis	9.49e-07	0.000287	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IL6—psoriasis	8.69e-07	0.000263	CbGpPWpGaD
